To read an MSNBC article about the trials of Arbaclofen for reduction of autism symptoms, copy and paste this URL;http://www.msnbc.msn.com/id/47630513/ns/health-mental_health/#.T8zqZbDOy5I
Here is a short passage from that article:
"As Jack's experience suggests, that may be about to change. Researchers are conducting advanced trials of the first drugs expressly designed to correct the genetically induced signaling problems in the brain that result in autism. The early indications are positive enough to offer new hope for families and spark interest from drug companies. For patients, this research "may not solve their autism, but it may solve aggression, it may solve sensory overload, which leads to a lot of behavioral issues," says Isaac Pessah, an autism researcher at the University of California at Davis, who has not been involved in any of the drug trials."
Here is a short passage from that article:
"As Jack's experience suggests, that may be about to change. Researchers are conducting advanced trials of the first drugs expressly designed to correct the genetically induced signaling problems in the brain that result in autism. The early indications are positive enough to offer new hope for families and spark interest from drug companies. For patients, this research "may not solve their autism, but it may solve aggression, it may solve sensory overload, which leads to a lot of behavioral issues," says Isaac Pessah, an autism researcher at the University of California at Davis, who has not been involved in any of the drug trials."
According to the article the drug is still being studied in small trials and access by those not enrolled in these studies is still years away.
No comments:
Post a Comment